The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation
Age and Ageing2008Vol. 38(2), pp. 156–162
Citations Over TimeTop 1% of 2008 papers
Abstract
frail older inpatients with AF are significantly less likely to receive warfarin than non-frail and appear more vulnerable to adverse clinical outcomes, with and without antithrombotic therapy.
Related Papers
- → Experimental antithrombotic effect of potatoes harvested in the autumn(2012)5 cited
- → Novel 2-Aminobenzamides as Potential Orally Active Antithrombotic Agents(2012)3 cited
- → Antithrombotic Therapy: Focus on the Elderly(2017)1 cited
- Novel antithrombotic therapy.(1993)
- → Antithrombotic therapy in the elderly - are there differences?(2017)